Insider Selling: Cabot (NYSE:CBT) CEO Sells $7,943,066.43 in Stock

Cabot Corporation (NYSE:CBT) CEO Sean Keohane sold 91,923 shares of the stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $86.41, for a total value of $7,943,066.43. Following the transaction, the chief executive officer owned 404,134 shares in the company, valued at $34,921,218.94. This trade represents a 18.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Cabot Price Performance

Cabot stock traded up $0.58 during trading on Tuesday, reaching $87.03. The company had a trading volume of 428,298 shares, compared to its average volume of 483,177. The firm has a market capitalization of $4.49 billion, a PE ratio of 24.52, a price-to-earnings-growth ratio of 11.45 and a beta of 0.84. The firm’s 50-day simple moving average is $87.91 and its 200 day simple moving average is $80.05. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. Cabot Corporation has a 1-year low of $58.33 and a 1-year high of $94.53.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. The company had revenue of $982.00 million during the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, equities research analysts anticipate that Cabot Corporation will post 6.32 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be given a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio is 53.24%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. UBS Group lowered their price objective on Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a report on Wednesday, August 5th. Truist Financial set a $100.00 target price on Cabot in a report on Wednesday, August 5th. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a research report on Sunday. JPMorgan Chase & Co. lifted their price target on Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research note on Friday. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $89.00.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Torren Management LLC acquired a new position in shares of Cabot during the 4th quarter valued at about $26,000. Rothschild Investment LLC increased its position in Cabot by 170.4% during the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after purchasing an additional 259 shares during the last quarter. Global Retirement Partners LLC raised its stake in Cabot by 1,606.9% during the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 466 shares during the period. Geneos Wealth Management Inc. raised its stake in Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the period. Finally, Danske Bank A S acquired a new position in Cabot in the 3rd quarter valued at about $38,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.